Hormone Refractory Prostate Cancer (HRPCA) or Castrate-Resistant Prostate Cancer (CRPC), a type of prostate cancer that typically recurs after having hormonal therapy, is now under the spotlight in prostate cancer market. Due to the high unmet clinical need associated with limited survival periods, intensifying HRPCA prevalence and fast-emerging treatment modifications, the global HRPCA market is poised to witness an unprecedented growth.

A promising drug pipeline, evolving treatment patterns and augmented patient awareness are the factors that would largely drive the market growth. Further, untapped patient population in the Asia Pacific region would lead to a large uptake of these treatments. On the other hand, premium pricing of HRPCA drugs, uncertain reimbursement policies and limited survival periods are likely to curtail the market growth.

Notably, physicians reluctance towards adoption of these premium treatments would remain a key challenge for the leading innovators. However, the untapped non-metastatic CRPC market would open new avenues for the new and existing companies. Additionally, emerging economies with undiagnosed patient population and mounting prevalence would provide growth opportunities in future.

The market is expected to register substantial growth attributed to the strategies adopted by leading market players. One of the key strategies adopted is collaboration agreement. For instance, in 2009, Astellas Pharma Inc. entered into an agreement with Medivation, Inc. to co-develop and co-commercialize MDV3100 (now Xtandi) for the treatment of HRPCA.

To provide a detailed market assessment, the report segments the HRPCA market on the basis of therapy type and geography. Based on therapy type, the market is segmented across various levels such as Chemotherapy, Hormonal Therapy, Immunotherapy and Radiation Therapy. The report covers a geographic breakdown and a detailed analysis of each of the aforesaid segments across North America, Europe, Asia Pacific, and LAMEA.

A comprehensive competitive analysis and the profiles of major market players such as Astellas Inc., Sanofi S.A, Dendreon Corporation, Bayer AG, Johnson & Johnson, and others are also provided in the report.

KEY MARKET BENEFITS:

This report provides an extensive analysis of the current and emerging market trends and dynamics in the global HRPCA market

The HRPCA market scenario is comprehensively analysed in accordance with the key regions and leading countries

Extensive research is done for the market by therapy type which instils a clear understanding regarding the currently used chemotherapy and hormonal therapy drugs and evolving role of immunotherapies and radiopharmaceuticals

The report covers the detailed quantitative analysis of the current market and estimations through 2014-2020, which would enable the stakeholders to capitalize on prevailing market opportunities

The studies evaluating competitive landscape and value chain has been taken into account in this report to help in understanding the competitive environment across the geographies

A detailed SWOT analysis enables to study the internal environment of the leading companies for strategy formulation

Owing to an emerging pipeline in the HRPCA market, clinical studies have also been taken into account to better understand the market potential and opportunities

Competitive intelligence highlights the business practises followed by leading market players across geographies

KEY MARKET SEGMENTS:

The Global HRPCA market segmentation is illustrated below:

HRPCA Market By Therapy Type

Chemotherapy

Cytotoxic Agents

Hormonal Therapy

Anti-Androgens

Immunotherapy

Radiation Therapy

Radio-Pharmaceuticals

HRPCA Market By Geography

North America

Europe

Asia-Pacific

LAMEA

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR)
encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only
engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates
and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within
each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors
and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis
and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and
allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning

Technologically sophisticated and reliable insights through well audited and veracious research methodology

Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to:
Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

Validates and improves the data quality and strengthens research proceeds

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.